Oncology bibliography

Definition, classification and symptoms. The current disease classification is distinguished from the 1864 descriptive label.

Malignant Neoplasms: cell morphology, prominent nucleoli, mitoses and epithelial versus mesenchymal classification.

1856; pp. 35–37 describe fibres, elongated nuclei and fibroplastic cells and discuss recurrence or malignant behaviour. Publication and author verified against wellcomecollection.org/works/wmmt58cd. The historical category is not treated as a unique present diagnosis.

Current patient information headed Breast Cancer Recurrence: local, regional and distant return, and factors affecting recurrence risk.

Pages 548–549; contemporary discussion of caustics, chemical injection and purported prevention of recurrence. Cited as evidence of what was proposed, not as support for those treatments.

Thomas Weeden Cooke, pp. 131–135, nonoperative case records. Period observations of palliation or altered symptoms are not evidence of eradication of cancer.

NG101; pretreatment assessment, surgery, systemic therapy planning and adjuvant treatment.

Imaging, core needle biopsy, pathology, biomarkers and staging.

Lumps, nipple and skin changes, pain and signs of distant disease.

How leukemia starts; Features and symptoms, acute versus chronic disease.

What is leukemia?; Symptoms; Diagnosis. Official National Library of Medicine overview.

Introduction; Classification; Findings at Diagnosis table; Leukemoid reaction. Review February 2026.

PDQ Health Professional Version; “Pathophysiology of N&V” describes visceral afferent pathways and coordinated efferent responses.

Sections on types of cancer, including carcinoma, sarcoma, leukaemia, lymphoma and melanoma.

British Journal of cancer 122, 1630–1637 (2020). Publisher record. Primary article or institutional bibliographic record.

PLoS Genetics 8, e1002797 (2012). Publisher record. Primary article or institutional bibliographic record.

Nature 447, 1130–1134 (2007). Publisher record. Primary article or institutional bibliographic record.

cancer biological cell 17, 28–40 (2010). Publisher record. Primary article or institutional bibliographic record.

PNAS 105, 3903–3908 (2008). Publisher record. Primary article or institutional bibliographic record.

biological cell 120, 635–647 (2005). Publisher record. Primary article or institutional bibliographic record.

PNAS 99, 15560–15565 (2002). Publisher record. Primary article or institutional bibliographic record.

Nature Genetics 49, 1567–1575 (2017). Publisher record. Primary article or institutional bibliographic record.

genes & Development 15, 3243–3248 (2001). Publisher record. Primary article or institutional bibliographic record.

Nature 462, 739–744 (2009). Publisher record. Primary article or institutional bibliographic record.

cancer Discovery 6, 914–929 (2016). Publisher record. Primary article or institutional bibliographic record.

Publisher record. Primary research article.

Nature 575, 217–223 (2019). Publisher record. Primary article or institutional bibliographic record.

First author: L. A. Donehower.

Primary research: www.nature.com/articles/356215a0

Cited passages: Donehower and colleagues, 1992, abstract and spontaneous-tumour observations.

First author: Brian J. Druker.

Primary research: www.nature.com/articles/nm0596-561

Cited passages: Druker and colleagues, 1996, abstract and BCR-ABL-positive versus negative cellular experiments.

Megan I. Brasher and coauthors.

Makoto Horiuchi and coauthors.

Cited material: Mosaic Nrf2 deletion, unstressed controls and 4NQO exposure.

David Fernandez-Antoran and coauthors.

Cited material: Mouse lineage tracing with irradiation and antioxidant intervention.

Iwo Kucinski and coauthors.

Cited material: Figures 5–7; antioxidant response, redox measurements and mosaic CncC activation.

Proceedings of the National Academy of Sciences 109, 15101–15108 (2012). doi.org/10.1073/pnas.1213353109

Cell 139, 891–906 (2009). doi.org/10.1016/j.cell.2009.10.027

First author: W. S. Hayward.

Primary source: www.nature.com/articles/290475a0

Relevant passages: pp. 475–480, promoter insertion and cellular oncogene activation.

First author: Tony Hunter.

Primary source: pmc.ncbi.nlm.nih.gov/articles/PMC348484/

Relevant passages: pp. 1311–1315, identification of phosphotyrosine in kinase products.

First author: Dominique Stehelin.

Primary source: www.nature.com/articles/260170a0

Relevant passages: pp. 170–173, hybridization of transformation-related probe to normal avian DNA.

First author: Howard M. Temin.

Primary source: pubmed.ncbi.nlm.nih.gov/4316301/

Relevant passages: pp. 1211–1213, RNA-dependent DNA synthesis in virion preparations.

First author: Peyton Rous.

Primary source: pmc.ncbi.nlm.nih.gov/articles/PMC2124874/

Relevant passages: pp. 397–411, transmission with material separated from tumour cells.

Richard A. Morgan and coauthors. 2010. Molecular Therapy 18, 843–851.

Jesse M. Zaretsky and coauthors. 2016. New England Journal of Medicine 375, 819–829.

Sanjeev Mariathasan and coauthors. 2018. Nature 554, 544–548.

Maartje W. Rohaan and coauthors. 2022. New England Journal of Medicine 387, 2113–2125.

Kari R. Fischer and coauthors. 2015. Nature 527, 472–476.

Ievgenia Pastushenko and coauthors. 2018. Nature 556, 463–468.

Jeff H. Tsai and coauthors. 2012. Cancer Cell 22, 725–736.

Jing Yang and coauthors. 2004. Cell 117, 927–939.

Anirudh Prahallad and coauthors. 2012. Nature 483, 100–103.

Iñigo Martincorena and coauthors. 2017. Cell 171, 1029–1041.e21.

Michael S. Lawrence and coauthors. 2013. Nature 499, 214–218.

Francisco Sanchez-Vega and coauthors. 2018. Cell 173, 321–337.e10.

Berna C. Özdemir and coauthors. 2014. Cancer Cell 25, 719–734.

Cristovão M. Sousa and coauthors. 2016. Nature 536, 479–483.

Published erratum: doi.org/10.1038/nature19851. Consult the corrected article.

Ayuko Hoshino and coauthors. 2015. Nature 527, 329–335.

Jeffrey Wyckoff and coauthors. 2004. Cancer Research 64, 7022–7029.

Akira Orimo and coauthors. 2005. Cell 121, 335–348.

Authors: Kevin J. Cheung.

Primary source: pmc.ncbi.nlm.nih.gov/articles/PMC3941206/

Cited material: Organoid invasion, basal-marker leader cells, and K14/p63 knockdown.